BAKX Therapeutics

Team
Science
Platform
Pipeline
Media & Publications
Careers

Fierce Biotech

July 26, 2021
Fierce Biotech

Ipsen pens early-stage, $14.5M programmed cell death cancer deal with BAKX Therapeutics
read more

We want to hear from you.

© 2022 BAKX Therapeutics. All rights reserved.

New York
Boston
Press

LinkedIn
Twitter